Abstract
In the realm of clinical chemistry, the field of clinical proteomics, that is, the application of proteomic methods for understanding mechanisms and enabling diagnosis, prediction, measurement of activity, and treatment response in disease, is first and foremost a discovery and research tool that feeds assay development downstream. Putative new assay candidates generated by proteomics discovery projects compete with well-established assays with known indications, well-described performance, and of known value in specific clinical settings. Careful attention to the many options available in the design, execution, and interpretation of clinical proteomics studies is thus necessary for translation into clinical practice. We here review and discuss important options associated with clinical proteomics endeavors stretching from the planning phases to the final use in clinical chemistry.
Original language | English |
---|---|
Journal | Proteomics - Clinical Applications |
Volume | 9 |
Issue number | 1-2 |
Pages (from-to) | 235-252 |
ISSN | 1862-8346 |
DOIs | |
Publication status | Published - Feb 2015 |
Keywords
- Biomarker
- Clinical proteomics
- Diagnostics
- LC-MS/MS
- Proteomic classifiers
- Clinical Medicine
- Biomarkers/analysis
- Humans
- Proteomics/methods
- Proteome/analysis